Candesartan Krka 4 mg tablets EFG

Spain
Brand name Candesartan Krka 4 mg tablets EFG
Form tablets
Active substance / Dosage
Prescription type Prescription Only Medicine
Registration number 76519
Candesartan Krka 4 mg tablets EFG tablets

Package leaflet: Information for the user

Introduction

Package leaflet: information for the patient

Candesartán Krka 4 mg tablets EFG

candesartan cilexetil

Read this entire leaflet carefully before you start taking this medicine, because it contains important information for you.

  • Keep this leaflet, as you may need to read it again.
  • If you have any questions, consult your doctor or pharmacist.
  • This medicine has been prescribed for you only, and you should not give it to other people, even if they have the same symptoms as you, because it could harm them.
  • If you experience any adverse reactions, consult your doctor or pharmacist, even if they are adverse reactions not listed in this leaflet. See section 4.

Contents of this leaflet

  1. What Candesartán Krka is and what it is used for
  2. What you need to know before taking Candesartán Krka
  3. How to take Candesartán Krka
  4. Possible side effects
  5. How to store Candesartán Krka
  6. Contents of the pack and other information

1. What Candesartán Krka is and what it is used for

The name of the medicine is Candesartán Krka. The active substance is candesartán cilexetilo. It belongs to a group of medicines called angiotensin II receptor antagonists. It works by relaxing and widening the blood vessels, which helps lower blood pressure. It also helps your heart pump blood to all parts of your body.

This medicine is used for:

  • Treatment of high blood pressure (hypertension) in adult patients and children and adolescents aged 6 to 18 years.
  • Candesartán can be used to treat heart failure in adult patients with reduced heart muscle function when angiotensin-converting enzyme (ACE) inhibitors cannot be used, or as an addition to ACE inhibitors when symptoms persist despite treatment and mineralocorticoid receptor antagonists (MRAs) cannot be used (ACE inhibitors and MRAs are groups of medicines used to treat heart failure).

2. What you need to know before taking Candesartán Krka

Do not take Candesartán Krka

  • if you are allergic to candesartan cilexetil or to any of the other ingredients of this medicine (listed in section 6),
  • if you are more than 3 months pregnant. (In any case, it is better to avoid taking Candesartán Krka also during early pregnancy – see Pregnancy section),
  • if you have severe liver disease or biliary obstruction (a problem with bile flow from the gallbladder),
  • if the patient is a child under 1 year of age,
  • if you have diabetes or impaired kidney function and are being treated with a blood pressure-lowering medicine containing aliskiren.

If you are unsure whether you fall into any of these categories, consult your doctor or pharmacist before taking Candesartán Krka.

Warnings and precautions

Talk to your doctor or pharmacist before starting Candesartán Krka:

  • if you have heart, liver or kidney problems, or are undergoing dialysis,
  • if you have recently received a kidney transplant,
  • if you are experiencing vomiting, have recently had severe vomiting, or have diarrhoea,
  • if you have an adrenal gland disorder called Conn’s syndrome (also known as primary hyperaldosteronism),
  • if you have low blood pressure,
  • if you have ever had a stroke,
  • if you are pregnant (or planning to become pregnant), you must inform your doctor. The use of Candesartán Krka is not recommended during early pregnancy and must not be used after the third month of pregnancy as it may cause serious harm to your baby (see Pregnancy section).
  • if you are taking any of the following medicines used to treat high blood pressure:
    • an ACE inhibitor (e.g. enalapril, lisinopril, ramipril), particularly if you have kidney problems related to diabetes.
    • aliskiren.
    • if you are taking an ACE inhibitor together with a medicine belonging to the class of drugs known as mineralocorticoid receptor antagonists (MRA). These medicines are used to treat heart failure (see “Other medicines and Candesartán Krka”).

Your doctor may monitor your kidney function, blood pressure, and levels of electrolytes (e.g. potassium) in your blood at regular intervals.

See also the information under the heading "Do not take Candesartán Krka".

Contact your doctor if you experience abdominal pain, nausea, vomiting or diarrhoea after taking Candesartán Krka. Your doctor will decide whether to continue treatment. Do not stop taking Candesartán Krka on your own.

If you are in any of these situations, your doctor may want to see you more frequently and carry out certain tests.

If you are scheduled for surgery, inform your doctor or dentist that you are taking Candesartán Krka. This is because candesartan, in combination with certain anaesthetics, may cause excessive lowering of blood pressure.

Children and adolescents

Candesartán Krka has been studied in children. For further information, consult your doctor or pharmacist. Candesartán Krka must not be given to children under 1 year of age due to the potential risk to kidney development.

Other medicines and Candesartán Krka

Tell your doctor or pharmacist if you are taking, have recently taken, or might need to take any other medicines.

Candesartán Krka may affect how some medicines work, and some medicines may influence the effect of candesartan. If you are taking certain medicines, your doctor may need to perform blood tests periodically.

In particular, inform your doctor if you are taking any of the following medicines:

    • Other medicines to lower your blood pressure, including beta-blockers, diazoxide, and so-called ACE inhibitors such as enalapril, captopril, lisinopril or ramipril.
  • Non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen, naproxen, diclofenac, celecoxib or etoricoxib (medicines used to relieve pain and inflammation).
    • Acetylsalicylic acid (if taking more than 3 g per day) (a medicine used to relieve pain and inflammation).
  • Potassium supplements or salt substitutes containing potassium (medicines that increase potassium levels in your blood).
  • Heparin (a medicine used to thin the blood).
  • Cotrimoxazole (an antibiotic), also known as trimethoprim/sulfamethoxazole.
  • Diuretics (medicines that increase urine production).
  • Lithium (a medicine used for mental health conditions).

Your doctor may need to adjust your dose and/or take other precautions:

  • If you are taking an ACE inhibitor or aliskiren (see also information under the headings “Do not take Candesartán Krka” and “Warnings and precautions”).
  • If you are being treated with an ACE inhibitor together with other medicines for heart failure known as mineralocorticoid receptor antagonists (MRA) (e.g. spironolactone, eplerenone).

Taking Candesartán Krka with food, drinks and alcohol

Candesartán Krka can be taken with or without food.

When prescribed Candesartán Krka, consult your doctor before drinking alcohol. Alcohol may make you feel faint or dizzy.

Pregnancy, breastfeeding and fertility

If you are pregnant or breastfeeding, think you may be pregnant, or are planning to become pregnant, consult your doctor or pharmacist before using this medicine.

Pregnancy

Inform your doctor if you are pregnant (or might be). Your doctor will usually advise you to stop taking candesartan before becoming pregnant or as soon as pregnancy is confirmed, and will recommend an alternative antihypertensive treatment. Candesartan is not recommended during early pregnancy and must not be used after the third month of pregnancy, as it may cause serious harm to the unborn baby when used from that stage onward.

Breastfeeding

Inform your doctor if you are planning to start or are currently breastfeeding. Candesartán is not recommended for women who are breastfeeding. Your doctor may decide to prescribe a more suitable treatment if you intend to breastfeed, especially if your baby is a newborn or premature.

Driving and using machines

Some patients may feel tired or dizzy while taking candesartan. If this happens to you, do not drive or operate tools or machinery.

Candesartán Krka contains lactose and sodium

If your doctor has informed you that you have an intolerance to certain sugars, discuss this with your doctor before taking this medicine.

This medicine contains less than 1 mmol of sodium (23 mg) per tablet; therefore, it is essentially "sodium-free".

3. How to take Candesartán Krka

Follow exactly the instructions given by your doctor for taking this medicine. If you are unsure, consult your doctor or pharmacist again. It is important that you continue taking candesartan every day.

You may take candesartan with or without food.

Swallow the tablet with a little water.

Try to take the tablet at the same time each day. This will help you remember to take it.

High blood pressure

The recommended dose of candesartan is 8 mg once daily. Your doctor may increase this dose to 16 mg once daily and then to 32 mg once daily, depending on your blood pressure response.

In some patients, such as those with liver problems, kidney problems, or those who have recently lost body fluids (e.g. due to vomiting, diarrhoea, or diuretic treatment), your doctor may prescribe a lower starting dose.

Some black patients may have a reduced response to this type of medicine when used as monotherapy, and may require a higher dose.

Use in children and adolescents with high blood pressure

Children aged 6 to < 18 years:

The recommended starting dose is 4 mg once daily.

For patients weighing < 50 kg: in some patients whose blood pressure is not adequately controlled, your doctor may decide to increase the dose up to a maximum of 8 mg daily.

For patients weighing ≥ 50 kg: in some patients whose blood pressure is not adequately controlled, your doctor may decide to increase the dose to 8 mg once daily and then to 16 mg once daily.

Heart failure in adults

The recommended starting dose is 4 mg once daily. Your doctor may increase this dose by doubling it at intervals of at least 2 weeks up to a maximum of 32 mg once daily. Candesartan may be taken together with other medicines for heart failure, and your doctor will decide which treatment is appropriate for you.

If you take more Candesartán Krka than you should

If you take more candesartan than prescribed by your doctor, contact your doctor or pharmacist immediately.

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service at telephone number 91 562 04 20, indicating the medicine and the amount ingested.

If you forget to take Candesartán Krka

Do not take a double dose to make up for missed doses.

Simply take the next dose as scheduled.

If you stop taking Candesartán Krka

If you stop taking candesartan, your blood pressure may rise again. Therefore, do not stop taking candesartan without first consulting your doctor.

If you have any further questions about the use of this medicine, ask your doctor or pharmacist.

4. Possible adverse effects

Like all medicines, this medicine can cause adverse effects, although not everyone experiences them. It is important that you are aware of what these adverse effects could be.

Stop taking Candesartán Krka and see a doctor immediately if you experience any of the following allergic reactions:

  • Difficulty breathing, with or without swelling of the face, lips, tongue and/or throat,
  • Swelling of the face, lips, tongue and/or throat, which may cause difficulty swallowing,
  • Severe itching of the skin (with skin rash).

Candesartán Krka may cause a decrease in white blood cells. Your resistance to infections may decrease, and you may feel tired, have an infection, or fever. If this occurs, inform your doctor. Your doctor may perform blood tests from time to time to check that Candesartán Krka is not affecting your blood (agranulocytosis).

Other possible adverse effects include:

Common (affects 1 to 10 out of every 100 patients)

  • Dizziness/vertigo.
  • Headache.
  • Respiratory infection.
  • Low blood pressure. This may cause dizziness or fainting.
  • Changes in blood test results. An increase in blood potassium levels, especially if you already have kidney problems or heart failure. If this is severe, you may experience fatigue, weakness, irregular heartbeat, or tingling.
  • Effects on kidney function, especially if you already have kidney problems or heart failure. In very rare cases, kidney failure may occur.

Very rare (affects fewer than 1 in 10,000 patients)

  • Swelling of the face, lips, tongue and/or throat.
  • A decrease in red or white blood cells. You may feel tired, or have an infection or fever.
  • Skin rash, hives (urticaria).
  • Itching.
  • Back pain, joint and muscle pain.
  • Changes in liver function, including inflammation of the liver (hepatitis). You may feel tired, have yellowing of the skin and whites of the eyes, and flu-like symptoms.
  • Intestinal angioedema: swelling in the intestine causing symptoms such as abdominal pain, nausea, vomiting, and diarrhoea.
  • Cough.
  • Nausea.
  • Changes in blood test results: a reduction in blood sodium levels. If severe, you may feel weak, lack energy, or have muscle cramps.

Frequency not known (cannot be estimated from available data)

  • Diarrhoea.

In children treated for hypertension, adverse effects appear to be similar to those seen in adults, but occur more frequently. Sore throat is a very common adverse effect in children but has not been reported in adults, and rhinorrhoea, fever, and increased heart rate are common in children but have not been reported in adults.

Reporting of adverse effects

If you experience any adverse effects, talk to your doctor or pharmacist, even if they are possible adverse effects not listed in this leaflet. You may also report them directly through the national reporting system: Spanish Pharmacovigilance System for Human Medicines: www.notificaram.es. By reporting adverse effects, you can help provide more information on the safety of this medicine.

5. Storage of Candesartan Krka

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date stated on the container after EXP. The expiry date is the last day of the month indicated.

Do not store above 30°C.

Medicines should not be disposed of via wastewater or household waste. Dispose of unused medicines and their containers at the SIGRE Point in your pharmacy. Ask your pharmacist how to dispose of medicines and containers you no longer need. This helps protect the environment.

6. Contents of the pack and other information

Composition of Candesartán Krka

  • The active substance is candesartan cilexetil. Each tablet contains 4 mg of candesartan cilexetil.
  • The other components are lactose monohydrate, corn starch, dibutyl sebacate, sodium lauryl sulfate, hydroxypropyl cellulose, calcium carmellose, and magnesium stearate (E572).

See section 2 “Candesartán Krka contains lactose and sodium”.

Nature of the product and pack contents

Candesartán Krka 4 mg tablets are white, round, biconvex, and scored on one side with a "4".

The score line is intended to facilitate breaking the tablet for ease of swallowing, but not to divide it into equal doses.

Blister packs containing 7, 10, 14, 28, 30, 50, 56, 60, 84, 90, 98, or 100 tablets are available.

Some pack sizes may not be marketed.

Marketing Authorization Holder and Manufacturer

KRKA, d.d., Novo mesto, Šmarješka cesta 6, 8501 Novo mesto, Slovenia

For further information about this medicinal product, please contact the local representative of the Marketing Authorization Holder:

KRKA Farmacéutica, S.L., C/ Anabel Segura 10, Pta. Baja, Oficina 1, 28108 Alcobendas, Madrid, Spain

This medicinal product is authorized in the Member States of the European Economic Area and in the United Kingdom under the following names:

Member State

Medicinal product name

United Kingdom

Candesartan cilexetil

France, Italy

Candesartan Krka

Netherlands

Candesartan cilexetil Krka

Spain

Candesartán Krka

Date of the most recent review of this leaflet: August 2025

Detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es/).